1. Home
  2. OMH vs NSRX Comparison

OMH vs NSRX Comparison

Compare OMH & NSRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ohmyhome Limited

OMH

Ohmyhome Limited

HOLD

Current Price

$0.80

Market Cap

24.4M

Sector

Finance

ML Signal

HOLD

NSRX

Nasus Pharma Ltd. Ordinary Shares

HOLD

Current Price

$2.90

Market Cap

32.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OMH
NSRX
Founded
2015
2019
Country
Singapore
Israel
Employees
N/A
7
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
24.4M
32.2M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
OMH
NSRX
Price
$0.80
$2.90
Analyst Decision
Hold
Strong Buy
Analyst Count
1
3
Target Price
N/A
$19.67
AVG Volume (30 Days)
17.4K
79.9K
Earning Date
05-12-2026
03-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$28.40
N/A
Revenue Next Year
$23.07
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.59
$1.98
52 Week High
$3.25
$9.99

Technical Indicators

Market Signals
Indicator
OMH
NSRX
Relative Strength Index (RSI) 32.26 50.24
Support Level $0.75 $2.04
Resistance Level $1.38 $3.48
Average True Range (ATR) 0.05 0.25
MACD -0.00 -0.01
Stochastic Oscillator 11.72 36.63

Price Performance

Historical Comparison
OMH
NSRX

About OMH Ohmyhome Limited

Ohmyhome Ltd is a data and technology-driven property technology company based in Singapore. Through its subsidiaries, it operates a one-stop-shop property platform that provides end-to-end property solutions and services for its customers, which comprises brokerage services and emerging and other services, such as home renovation and furnishing services, listing and research, mortgage referral, legal services, and insurance referral services. The company derives its revenues from two sources: revenue from brokerage services, property management services, and revenue from emerging and other services.

About NSRX Nasus Pharma Ltd. Ordinary Shares

Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions. It is engaged in developing a number of intranasal powder products based on its a microsphere technology, aimed at assisting patients in several acute emergency situations such as opioid overdose and anaphylactic shock. Its portfolio comprises a number of programs: Intranasal Naloxone completed pivotal study and Intranasal Epinephrine (phase 2) as well as a number of preclinical POC programs.

Share on Social Networks: